
EOS CHEMO: oncology line
Infusion sets, connecting sets, preparation accessories, the Lock-Lock CSTD system and A.d.M. Protect photoprotective bags.

PLASMA O3
We are developing a plasma-based approach to low-temperature sterilisation of medical devices. From research to trials in the pilot plant.
Technology undergoing validation
Inside the reactors ↗An alternative to develop.
A process to validate.
PLASMA O3 generates the sterilising agent from air using plasma and brings it to industrial scale. The dedicated page explains the approach, shows the plant and describes the current stage of development.
Explore the technology and projectBased in Concordia sulla Secchia, Modena, A.d.M. S.r.l. operates in the biomedical sector. Alongside its single-use medical devices and ISIMIX system, the company is pursuing research into low-temperature sterilisation.
Discover ISIMIX for hospital pharmacies, explore our four single-use product lines or learn about our co-funded projects. For product and collaboration enquiries, contact ADM.
A new approach to chemotherapy preparation. Fast, precise and innovative.
ISIMIX System consists of dosing modules compatible with existing hospital pharmacy equipment. Multiple ISIMIX modules allow different therapies to be prepared at the same time.
EOS CHEMO for oncology, EIR LINE for extension lines and accessories, DIKE LINE for infusion sets and KHORS LINE for transfusion sets. All four lines are latex-free; materials and configurations are described in the individual product details.

Infusion sets, connecting sets, preparation accessories, the Lock-Lock CSTD system and A.d.M. Protect photoprotective bags.

Extension lines made from materials free from harmful plasticisers. Available in a wide range of materials, diameters, lengths and configurations.

Infusion sets made from materials free from harmful plasticisers, with configurations covering most hospital infusion procedures.

Transfusion sets designed to stringent quality standards and assembled using modern automated equipment.
Projects supported by the Emilia-Romagna Region and the European Union under the Coesione Italia 21–27 programme.

Development of an alternative sterilisation plant based on cold plasma technology, through expenditure on generator components, patent-related costs and specialist testing.
Regional funding helped support process validation and the setup of a dedicated area, accelerating entry into a market with limited existing coverage.
Explore PLASMA O3 technology →PLASMA-Ster enabled the construction of the pilot plant on which PLASMA O3 is being developed today.
Participation in Medica 2023 to expand the company's single-use medical device market in Arab countries and introduce an innovative sterilisation system as an alternative to traditional methods, building relationships with other interested biomedical manufacturers.
ADM presents the ISIMIX chemotherapy preparation system, four lines of single-use medical devices and the PLASMA-Ster project dedicated to cold plasma sterilisation. Meet the company.
ISIMIX is a system of dosing modules for chemotherapy preparation in hospital pharmacies. Multiple modules enable different therapies to be prepared in parallel. To discuss compatibility with your facility's equipment, email ADM.
EOS CHEMO includes connecting sets, infusion sets and spikes for oncology. EIR LINE includes extension lines, stopcocks, caps and valves. DIKE LINE covers infusion sets and KHORS LINE covers transfusion sets.
Open the product details and select the enquiry button: your email app will open with a prepared subject and message. You can also email info@admsrl.eu, specifying the product line, your organisation and the information you need.
The company is located at Via Brodolini, units 2/4/6 – 41033 Concordia sulla Secchia (MO), Italy. View address and contact details.
Email us about products, supply or collaborations and we will get back to you.
Via Brodolini, units 2/4/6
41033 Concordia sulla Secchia (MO)
Telephone: 0535 061155
Email: info@admsrl.eu
Contact usMedical devices.
Applied research.
Direct dialogue.